Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease

Aquaretic Treatment in Polycystic Kidney Disease

(2012) Rudolf P. Wüthrich et al.   NEW ENGLAND JOURNAL OF MEDICINE

DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease

(2010) Zhen Hong et al.   BRAIN

A comprehensive and non-prefractionation on the protein level approach for the human urinary proteome: touching phosphorylation in urine

(2010) Qing-Run Li et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

Identification of Glutathione S -Transferase Pi as a Protein Involved in Parkinson Disease Progression

(2009) Min Shi et al.   AMERICAN JOURNAL OF PATHOLOGY

Advances in the pathogenesis and treatment of polycystic kidney disease

(2009) Vishal Patel et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress

(2009) Massimo Cugno et al.   TRENDS IN MOLECULAR MEDICINE

Complement Mutation-AssociatedDe NovoThrombotic Microangiopathy Following Kidney Transplantation

(2008) M. Le Quintrec et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Pkd1 Inactivation Induced in Adulthood Produces Focal Cystic Disease

(2008) A. Takakura et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Unified Criteria for Ultrasonographic Diagnosis of ADPKD

(2008) Y. Pei et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Overexpression of complement-component genes in Han:SPRD rats a model of polycystic kidney disease

(2008) S.J. Burtey et al.   KIDNEY INTERNATIONAL

Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patients

(2008) Xianyin Lai et al.   Proteomics Clinical Applications